Maternal uniparental disomy of chromosome 2
diseaseOn this page
Also known as maternal uniparental disomy of chromosome type 2UPD(2)mat
Summary
Maternal uniparental disomy of chromosome 2 (MONDO:0019910) is a disease. A subtype of chromosome 2 disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Phenotypes (HPO): 28
Clinical features
Signs & symptoms
Clinical features (HPO)
28 HPO clinical features (Orphanet curated; top 28 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0001511 | Intrauterine growth retardation | Very frequent (80-99%) |
| HP:0001560 | Abnormality of the amniotic fluid | Very frequent (80-99%) |
| HP:0008897 | Postnatal growth retardation | Very frequent (80-99%) |
| HP:0000821 | Hypothyroidism | Frequent (30-79%) |
| HP:0001562 | Oligohydramnios | Frequent (30-79%) |
| HP:0002643 | Neonatal respiratory distress | Frequent (30-79%) |
| HP:0003028 | Abnormality of the ankles | Frequent (30-79%) |
| HP:0004639 | Elevated amniotic fluid alpha-fetoprotein | Frequent (30-79%) |
| HP:0005781 | Contractures of the large joints | Frequent (30-79%) |
| HP:0000041 | Chordee | Occasional (5-29%) |
| HP:0000047 | Hypospadias | Occasional (5-29%) |
| HP:0000083 | Renal insufficiency | Occasional (5-29%) |
| HP:0000110 | Renal dysplasia | Occasional (5-29%) |
| HP:0000546 | Retinal degeneration | Occasional (5-29%) |
| HP:0000824 | Decreased response to growth hormone stimulation test | Occasional (5-29%) |
| HP:0001177 | Preaxial hand polydactyly | Occasional (5-29%) |
| HP:0001622 | Premature birth | Occasional (5-29%) |
| HP:0001763 | Pes planus | Occasional (5-29%) |
| HP:0002089 | Pulmonary hypoplasia | Occasional (5-29%) |
| HP:0002652 | Skeletal dysplasia | Occasional (5-29%) |
| HP:0002721 | Immunodeficiency | Occasional (5-29%) |
| HP:0004209 | Clinodactyly of the 5th finger | Occasional (5-29%) |
| HP:0004880 | Respiratory infections in early life | Occasional (5-29%) |
| HP:0005268 | Spontaneous abortion | Occasional (5-29%) |
| HP:0008209 | Premature ovarian insufficiency | Occasional (5-29%) |
| HP:0008440 | C1-C2 vertebral abnormality | Occasional (5-29%) |
| HP:0008689 | Bilateral cryptorchidism | Occasional (5-29%) |
| HP:0001263 | Global developmental delay | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | maternal uniparental disomy of chromosome 2 |
| Mondo ID | MONDO:0019910 |
| Orphanet | 96179 |
| ICD-11 | 2067230711 |
| SNOMED CT | 766237006 |
| UMLS | C4707718 |
| MedGen | 1631626 |
| GARD | 0019331 |
| Is cancer (heuristic) | no |
Also known as: maternal uniparental disomy of chromosome type 2 · UPD(2)mat
Disease family
Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › chromosomal disorder › autosomal anomaly › chromosome 2 disorder › maternal uniparental disomy of chromosome 2
Related subtypes (4): mosaic trisomy 2, partial deletion of chromosome 2, partial duplication of chromosome 2, ring chromosome 2
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.